Cone-beam CT is preferential to multislice spiral CT for hard-contrast objects, study says.
There was not that great a difference between cone-beam computed tomography (CBCT) and multislice spiral computed tomography (MSCT) with respect to dose and image quality, according to the results of a study published recently in Investigative Radiology. However, study results did show that use of MSCT was preferential for soft-contrast objects and CBCT for hard-contrast objects.
These results were taken from a study by Alexander A. Schegerer, PhD, of the department of medical and occupational radiation protection, Federal Office for Radiation Protection, Neuherberg, and colleagues who compared patient exposure and image quality of various CBCT and MSCT protocols for abdominal and genitourinary imaging.
According to Schegerer, the application of CBCT for image-guided interventions outside the radiology department has strongly increased.
“Cone-beam computed tomography has been established in many different clinical fields, for example, neurology, otolaryngology, cardiology, abdominal angiography, musculoskeletal imaging, and, urology,” Schegerer said. “To date, there are only few reports in the literature on radiation doses and image quality for CBCT.”
Schegerer and colleagues examined the CBCT and MSCT protocols for imaging soft tissue and hard-contrast objects at varying dose levels.
CBCT protocols had an effective radiation dose that ranged between 0.35 mSv to 18.1 mSv, with the local skin dose reaching doses as high as 190 mGy.
“The effective dose necessary to realize the same contrast-to-noise ratio with CBCT and MSCT depended on the MSCT convolution kernel: the MSCT dose was smaller than the corresponding CBCT dose for a soft kernel but higher than that for a hard kernel,” Schegerer said.
The researchers also compared noise-power spectrum of the two protocols and found that the spectrum of images taken with CBCT at tube voltages of 85/90 kV(p) were at least half of that of images measured at 103/11 kV(p) at any chosen spiral frequency.
“As compared with MSCT using a medium-hard convolution kernel, CBCT produces images at medium noise levels and, simultaneously, medium spatial resolution at approximately the same dose,” Schegerer said. “It is well suited for visualizing hard-contrast objects in the abdomen with relatively low image noise and patient dose.”
He added that for the detection of low-contrast objects at standard tube voltages of approximately 120 kV(p), however, MSCT should be preferred.
Finally, the researchers noted that it is indispensable to carefully justify and optimize the CBCT protocols predefined by the manufacturer to the specific clinical needs of different types of examinations. The collimation of the radiation field has to be adapted to the clinically relevant body region to reduce patient exposure.
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.